Literature DB >> 8037446

Human pancreatic-type and nonpancreatic-type ribonucleases: a direct side-by-side comparison of their catalytic properties.

S Sorrentino1, M Libonati.   

Abstract

The catalytic properties and substrate preference of several highly purified human ribonucleases from different organs and body fluids have been examined in detail using various low-molecular-weight compounds and single- or double-stranded polyribonucleotides as substrates. All single-stranded polyribonucleotides were degraded by nonpancreatic-type (npt) RNases at a slower rate than by pancreatic-type (pt) enzymes: ptRNases were 20 times more active on RNA and poly(U) substrates and more than 6000 times more active on poly(C). Pancreatic-type RNases degraded poly(C) faster than RNA, showing a strong preference for poly(C) over poly(U) with the following activity ratios: RNA/poly(C), 0.44; RNA/poly(U), 12; poly(C)/poly(U), 27. In contrast, nptRNases cleaved RNA more rapidly than synthetic homopolymers, preferring poly(U) over poly(C) with the following ratios: RNA/poly(C), 130; RNA/poly(U), 10; poly(C)/poly(U), 0.08. Human ptRNases degraded poly(A) and double-stranded polyribonucleotides about 100 and 400 times faster, respectively, than bovine RNase A. However, no measurable activity could be detected on these substrates with nptRNases. The activities of ptRNases on dinucleoside phosphates (CpN and UpN) or uridine and cytidine 2',3'-cyclic phosphates were similar to those of bovine RNase A; nptRNases, instead, cleaved only CpA and UpA at an appreciable rate. The effects of pH, ionic strength, and divalent cations on the activity of these ribonucleases were also investigated using yeast RNA as a substrate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037446     DOI: 10.1006/abbi.1994.1318

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  20 in total

1.  Structures of the two 3D domain-swapped RNase A trimers.

Authors:  Yanshun Liu; Giovanni Gotte; Massimo Libonati; David Eisenberg
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

2.  Structural properties of trimers and tetramers of ribonuclease A.

Authors:  A Nenci; G Gotte; M Bertoldi; M Libonati
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

3.  Ribonuclease-Activated Cancer Prodrug.

Authors:  Gregory A Ellis; Nicholas A McGrath; Michael J Palte; Ronald T Raines
Journal:  ACS Med Chem Lett       Date:  2012-02-28       Impact factor: 4.345

4.  The activity on double-stranded RNA of aggregates of ribonuclease A higher than dimers increases as a function of the size of the aggregates.

Authors:  M Libonati; M Bertoldi; S Sorrentino
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

5.  Role of aspartic acid 121 in human pancreatic ribonuclease catalysis.

Authors:  Deepak Gaur; Janendra K Batra
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

Review 6.  The RNase a superfamily: generation of diversity and innate host defense.

Authors:  Kimberly D Dyer; Helene F Rosenberg
Journal:  Mol Divers       Date:  2006-11       Impact factor: 2.943

7.  Green Chemistry Preservation and Extraction of Biospecimens for Multi-omic Analyses.

Authors:  Andrey P Tikunov; Jeremiah D Tipton; Timothy J Garrett; Sachi V Shinde; Hong Jin Kim; David A Gerber; Laura E Herring; Lee M Graves; Jeffrey M Macdonald
Journal:  Methods Mol Biol       Date:  2022

8.  Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant.

Authors:  Antonello Merlino; Giovanna Avella; Sonia Di Gaetano; Angela Arciello; Renata Piccoli; Lelio Mazzarella; Filomena Sica
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 10.  Oligomerization of bovine ribonuclease A: structural and functional features of its multimers.

Authors:  Massimo Libonati; Giovanni Gotte
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.